Market Expansion Acquisition activity indicates growth through strategic acquisitions (MAK-SYSTEM and IT Synergistics) and expansion of end-to-end blood management solutions, suggesting upsell opportunities for integrated donor, tissue, and blood management modules across new and existing customers.

Integrated Platform Strong value proposition as the sole connector across the donation-transplant ecosystem with interoperable, configurable solutions (iTransplant, Birth Tissue Acquisition, iReferral). Target hospitals, OPOs, and tissue/birth centers seeking end-to-end digital coordination to reduce delays and improve outcomes.

Market Penetration Large existing footprint in the U.S. donation-transplant market (70%+ of organs from deceased donors managed by iTransplant); opportunity to cross-sell to the 20,000+ medical professionals and 100+ agencies already using or evaluating the platform.

Technology Stack Robust cloud-based, scalable tech stack (AWS, Google Cloud, PostgreSQL, SQL Server, Terraform, Salesforce) favorable for security-conscious healthcare buyers; highlight migration or optimization services, data analytics, and integration projects to expand contract value.

Product Synergy Recent launches and partnerships (iReferral, advanced therapy capabilities, Birth Tissue Acquisition enhancements) create cross-sell opportunities to hospitals, OPOs, and blood centers seeking unified workflows, analytics, and expedited donor referrals across multiple program lines.